Would'st thou be in a dream: John Bunyan's The Pilgrim's Progress and Kurt Vonnegut's Slaughterhouse-Five
European Journal of American Culture · 2002
DOI: 10.1386/ejac.20.3.183 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of American Culture, 2002. Verfasst von Richard Hinchcliffe. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
This article establishes intertextual connections between Kurt Vonnegut's Slaughterhouse-Five and John Bunyan's The Pilgrim's Progress and describes how the Puritan conversion narrative form and the pilgrim narrative play a major part in Vonnegut's canonical anti-war novel. The protagonist Billy Pilgrim is seen as a modern personification of the Protestant work ethic, a successful, wealthy and hardworking businessman. He blithely espouses white Anglo-Saxon Protestant attitudes but becomes an evangelist for his science-fiction fantasies, which appear constructed from the religious materials around him and in his past. The narrative of Slaughterhouse-Five , like Tralfamadorian time, tries to destabilize the dominant Western master narrative typified by the linearity of The Pilgrim's Progress . If Dresden is seen as an inversion of Bunyan's Celestial City then its destruction is an indictment of capitalist progress born from pilgrim and conversion narratives.
Zitieren
APA
Hinchcliffe, R. (2002). Would'st thou be in a dream: John Bunyan's The Pilgrim's Progress and Kurt Vonnegut's Slaughterhouse-Five. European Journal of American Culture. https://doi.org/10.1386/ejac.20.3.183
Vancouver
Hinchcliffe R. Would'st thou be in a dream: John Bunyan's The Pilgrim's Progress and Kurt Vonnegut's Slaughterhouse-Five. European Journal of American Culture. 2002. doi:10.1386/ejac.20.3.183
BibTeX
@article{Hinchcliffe2002,
author = {Hinchcliffe, Richard},
title = {Would'st thou be in a dream: John Bunyan's The Pilgrim's Progress and Kurt Vonnegut's Slaughterhouse-Five},
journal = {European Journal of American Culture},
year = {2002},
doi = {10.1386/ejac.20.3.183}
}
EUVIMED